Halozyme Therapeutics: The Losing Streak Continues (HALO)
February 08, 2016 at 11:23 AM EST
Shares of Halozyme Therapeutics (NASDAQ:HALO) traded at a new 52-week low today of $7.44. This new low was reached on below average trading volume as 268,000 shares traded...